By leveraging advanced immunology, peptide engineering, cutting-edge AI technology, and novel formulation approaches, EDJEN BIOTECH’s aims to develop a first in class peptide-based vaccine platform which is scalable, adaptable, safe and efficacious.

EDJEN BIOTECH has a legacy of over two decades of scientific research conducted by a highly talented team who are dedicated to characterizing peptide-induced immune responses and creating peptide-based vaccines.

EDJEN BIOTECH is partnering with the most recognized republic health organizations to bring first in class vaccine solution worldwide.

 

EDJEN BIOTECH has developed a rapid and reliable way to create peptide-based vaccines for any pathogen of interest with a validated vaccine platform to predict, construct, synthesize, and formulate immunogenic peptides.

We are collaborating with the multiple research and public health organizations to develop and commercialize novel vaccine candidates.